Under ART treatment, the reduced expression levels of CDK2 and CDK4 further confirmed that ART inhibited these critical cell cycle proteins, leading to G1 phase arrest and effectively suppressing excessive proliferation of BLCA cells. This evidence concerns the gene CDK4 and bladder transitional cell carcinoma.